Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Chemoradiation for Esophageal Cancer
NCT01128387Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2010
- Primary completion
- Oct 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in esophageal cancer, sponsored by University of Wisconsin–Madison. Started May 2010; status: terminated.
02
Drugs
panitumumab
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01128387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128387.